Patent Assignment
Reel/Frame 055025/0890
Assignment of Assignor's Interest
Recorded: 2021-01-26
Pages: 8
Assignor
DAVIES, GARETH CHARLES GLYNDWR
Executed: 2019-06-17
Assignee
CELLTECH R&D LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE, UNITED KINGDOM
Covered Property
(1)
Gremlin-1 Antagonist for the Prevention and Treatment of Cancer
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 26, 2021
From: CELLTECH R&D LIMITED
To: UCB BIOPHARMA SPRL
Reel/Frame 055025/0910 →
Change of Name
Jan 26, 2021
From: UCB BIOPHARMA SPRL
To: UCB BIOPHARMA SRL
Reel/Frame 055107/0286 →
Corrective Assignment to Correct the Priority Number on the Executed Assignment Document Previously Recorded on Reel 055025 Frame 0890. Assignor(S) Hereby Confirms the Assignment of Entire Interest.
Feb 23, 2021
From: DAVIES, GARETH CHARLES GLYNDWR
To: CELLTECH R&D LIMITED
Reel/Frame 055364/0709 →
Assignment of Assignor's Interest
May 5, 2021
From: LEEDHAM, SIMON
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 056144/0774 →
Assignment of Assignor's Interest
May 19, 2021
From: ZANNETTINO, ANDREW; CLARK, KIMBERLEY; HEWETT, DUNCAN; PANAGOPOULOS, VASILIOS
To: THE UNIVERSITY OF ADELAIDE
Reel/Frame 056418/0948 →
Nunc Pro Tunc Assignment
Jun 2, 2026
From: THE UNIVERSITY OF ADELAIDE
To: ADELAIDE UNIVERSITY
Reel/Frame 075843/0344 →